Oarsman Capital, Inc. Johnson & Johnson Transaction History

Oarsman Capital, Inc.

$533 Million
Q3 2024

A detailed history of Oarsman Capital, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Oarsman Capital, Inc. holds 16,960 shares of JNJ stock, worth $2.66 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

16,960

Previous 16,779 1.08%

Holding current value

$2.66 Million

Previous $2.45 Million 12.07%

% of portfolio

0.52%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$145.48 - $167.38 $26,331 - $30,295	181 Added 1.08%	16,960 $2.75 Million
Q2 2024 Aug 12, 2024	BUY	$144.38 - $157.78 $64,826 - $70,843	449 Added 2.75%	16,779 $2.45 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $312,613 - $327,758	-2,014 Reduced 10.98%	16,330 $2.58 Million
Q4 2023 Feb 16, 2024	BUY	$145.6 - $158.88 $54,308 - $59,262	373 Added 2.08%	18,344 $2.88 Million
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $495,908 - $555,544	-3,184 Reduced 15.05%	17,971 $2.8 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $407,638 - $438,696	-2,641 Reduced 11.1%	21,155 $3.5 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $417,351 - $498,058	2,763 Added 13.14%	23,796 $3.69 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $25,311 - $28,406	158 Added 0.76%	21,033 $3.72 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $28,716 - $31,954	-178 Reduced 0.85%	20,875 $3.41 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $110,669 - $122,394	-658 Reduced 3.03%	21,053 $3.74 Million
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $121,767 - $138,284	770 Added 3.68%	21,711 $3.85 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $111,489 - $123,702	-715 Reduced 3.3%	20,941 $3.58 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $416,185 - $462,494	-2,577 Reduced 10.63%	21,656 $3.5 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $447,979 - $480,535	-2,809 Reduced 10.39%	24,233 $3.99 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $537,887 - $599,066	-3,514 Reduced 11.5%	27,042 $4.44 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $133,956 - $153,760	-977 Reduced 3.1%	30,556 $4.81 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $32,568 - $35,688	232 Added 0.74%	31,533 $4.7 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $1.42 Million - $1.72 Million	11,058 Added 54.63%	31,301 $4.4 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $1.33 Million - $1.84 Million	-11,933 Reduced 37.09%	20,243 $2.66 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $67,830 - $77,906	-532 Reduced 1.63%	32,176 $4.69 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $67,664 - $75,760	533 Added 1.66%	32,708 $4.23 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $78,690 - $86,544	600 Added 1.9%	32,175 $4.48 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $56,825 - $63,185	452 Added 1.45%	31,575 $4.41 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $96,183 - $115,758	783 Added 2.58%	31,123 $4.02 Million
Q3 2018 Nov 07, 2018	BUY	$121.58 - $142.88 $103,707 - $121,876	853 Added 2.89%	30,340 $4.19 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $50,506 - $55,734	423 Added 1.46%	29,487 $3.58 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $71,307 - $84,439	570 Added 2.0%	29,064 $3.73 Million
Q4 2017 Feb 08, 2018	SELL	$131.22 - $143.62 $62,854 - $68,793	-479 Reduced 1.65%	28,494 $3.98 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $3.75 Million - $3.92 Million	28,973	28,973 $3.77 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Johnson & Johnson Transaction History